iloprost and Shock--Cardiogenic

iloprost has been researched along with Shock--Cardiogenic* in 2 studies

Other Studies

2 other study(ies) available for iloprost and Shock--Cardiogenic

Article	Year
[Vasoplegic shock and myocardial infarction during administration of iloprost]. Presse medicale (Paris, France : 1983), 2005, Apr-23, Volume: 34, Issue:8 The association of vasoplegic shock and myocardial infarction in a patient under iloprost treatment for critical ischemia of the lower limbs has not previously been reported.. A 56 year-old man suffering from type 2 diabetes, hypertension and dyslipidemia developed critical ischemia of the right leg and was treated with iloprost. On the 19th day of infusion, he developed a vasoplegic shock with myocardial infarction. The shock resolved and he recovered from the infarction.. This case report indicates the need for reinforced blood pressure and electrocardiographic monitoring in diabetes patients treated with iloprost. Topics: Diabetes Mellitus, Type 2; Follow-Up Studies; Humans; Iloprost; Ischemia; Leg; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Time Factors; Vasodilator Agents	2005
Thrombolysis: go with the flow. Chest, 1991, Volume: 99, Issue:3 Topics: Animals; Blood Circulation; Dogs; Drug Interactions; Fibrinolysis; Humans; Iloprost; Shock, Cardiogenic; Thrombolytic Therapy; Tissue Plasminogen Activator	1991

Article

Year

[Vasoplegic shock and myocardial infarction during administration of iloprost].

Presse medicale (Paris, France : 1983), 2005, Apr-23, Volume: 34, Issue:8

The association of vasoplegic shock and myocardial infarction in a patient under iloprost treatment for critical ischemia of the lower limbs has not previously been reported.. A 56 year-old man suffering from type 2 diabetes, hypertension and dyslipidemia developed critical ischemia of the right leg and was treated with iloprost. On the 19th day of infusion, he developed a vasoplegic shock with myocardial infarction. The shock resolved and he recovered from the infarction.. This case report indicates the need for reinforced blood pressure and electrocardiographic monitoring in diabetes patients treated with iloprost.

Topics: Diabetes Mellitus, Type 2; Follow-Up Studies; Humans; Iloprost; Ischemia; Leg; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Time Factors; Vasodilator Agents

2005

Thrombolysis: go with the flow.

Chest, 1991, Volume: 99, Issue:3

Topics: Animals; Blood Circulation; Dogs; Drug Interactions; Fibrinolysis; Humans; Iloprost; Shock, Cardiogenic; Thrombolytic Therapy; Tissue Plasminogen Activator

1991